October 17, 2018

FFF is excited to announce that we have partnered with Tetraphase Pharmaceuticals to carry XERAVA™, the FIRST fully synthetic fluorocycline antibacterial to help fight resistant pathogens in cIAI.

XERAVA™ is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older.

XERAVA™ is immediately available for overnight shipping.

Please read the prescribing information to learn more about XERAVA™.